Citations (7)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Song Zhang, Xin Wang, Hao Gu & Jun-Qi Liu. (2022) Feasibility and Safety of Anlotinib Monotherapy for Patients with Previously Treated Advanced Esophageal Squamous Cell Carcinoma: A Real-World Exploratory Study. Cancer Management and Research 14, pages 1715-1727.
Read now
Read now
De-Bao Zhi, Zhi-Yu Wang, Tong Xie & Wen-Wen Tu. (2021) Influence of GSTP-1 Polymorphism on the Prognosis of Patients with High-Grade Glioma Who Received Temozolomide Plus Radiotherapy Adjuvant Treatment. International Journal of General Medicine 14, pages 10173-10183.
Read now
Read now
Rui-Tao Wang, Yang Zhao, An-Lei Wang, Yu-Ting Wang, Zhong-Ping Yin & Kai Chen. (2021) Efficacy and Safety of Regorafenib Monotherapy among Patients with Previously Treated Metastatic Colorectal Cancer in a Chinese Population: A Real-World Exploratory Study. International Journal of General Medicine 14, pages 5363-5373.
Read now
Read now
Articles from other publishers (4)
Margherita Vannucchi, Veronica Pennati, Clelia Mencaroni, Chiara Defraia, Ledi Bardhi, Francesca Castiglione, Cristiana Bellan & Camilla Eva Comin. (2023) KRAS Mutations Are Associated with Shortened Survival in Patients with Epithelioid Malignant Pleural Mesothelioma. Cancers 15:7, pages 2072.
Crossref
Crossref
Aujala Irfan Khan, Ghadi D Mashat, Mohammad Hazique, Kokab Irfan Khan, Prasana Ramesh, Suthasenthuran Kanagalingam, FNU Zargham Ul Haq, Nishok Victory Srinivasan & Safeera Khan. (2022) Efficacy and Safety of Apatinib in the Treatment of Chemotherapy-Refractory Metastatic Colorectal Cancer: A Systematic Review. Cureus.
Crossref
Crossref
Luisa Matos Canto, Jenilson Mota da Silva, Patrícia Valèria Castelo-Branco, Ingrid Monteiro da Silva, Leudivan Nogueira, Carlos Eduardo Fonseca-Alves, André Khayat, Alexander Birbrair & Silma Regina Pereira. (2022) Mutational Signature and Integrative Genomic Analysis of Human Papillomavirus-Associated Penile Squamous Cell Carcinomas from Latin American Patients. Cancers 14:14, pages 3514.
Crossref
Crossref
Xiaoyuan Li, Yang Cheng, Baorang Zhu, Ming Geng, Peng Yan & Mu Hu. (2022)
Implication of
VEGFR2
Polymorphism on the Prognosis of Anlotinib Monotherapy for Patients With Treatment-Refractory Advanced NSCLC: An Exploratory Study
. Technology in Cancer Research & Treatment 21, pages 153303382210809.
Crossref
Crossref